-
COST OF ACUTE ISCHAEMIC STROKE IN TURKIYE FROM THE SOCIAL HEALTH ORGANIZATION'S PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF IBRUTINIB-BASED INDUCTION WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA: A LIFETIME MARKOV MODEL BASED ON THE TRIANGLE TRIAL
Aug 11, 2026, 17:16 PM -
PREVALENCE OF DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEES) AMONG PATIENTS WITH EPILEPSY: A US CLAIMS ANALYSIS
Aug 11, 2026, 17:16 PM -
VALUE-TO-ACCESS (V2A): AN HTA FRAMEWORK FOR AI-ENABLED PRECISION MEDICINE
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUE OF SUBCUTANEOUS VERSUS INTRAVENOUS LECANEMAB IN EARLY ALZHEIMER'S DISEASE: A COST-BENEFIT ANALYSIS FROM A SOCIETAL PERSPECTIVE IN JAPAN
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW OF COST-EFFECTIVENESS, HEALTH-STATE UTILITY VALUES, AND HEALTHCARE COSTS AND RESOURCE USE EVIDENCE ASSOCIATED WITH SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
DISEASE BURDEN AND UNMET NEEDS IN CHINESE PATIENTS WITH PEUTZ-JEGHERS SYNDROME: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF FOUR FIRST-LINE ANTI-VIRAL TREATMENTS FOR HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CHINA
Aug 11, 2026, 17:16 PM -
WEIGHTING FOR GODOT: WHEN MAICS MOVE THE ESTIMATE BUT NOT THE UNCERTAINTY
Aug 11, 2026, 17:16 PM -
UPTAKE OF THE NICE SEVERITY MODIFIER: WHAT PROPORTION OF APPLICATIONS QUALIFY?
Aug 11, 2026, 17:16 PM -
ESTIMATING THE INPATIENT ECONOMIC BURDEN OF OBESITY IN GREECE: A NATIONWIDE POPULATION ATTRIBUTABLE FRACTION ANALYSIS USING REAL-WORLD HOSPITAL DATA
Aug 11, 2026, 17:16 PM -
NAVIGATING UNCERTAINTY IN ONCOLOGY: CONCORDANCE BETWEEN EUROPEAN HTA BODIES AND THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Aug 11, 2026, 17:16 PM -
OUTCOMES-BASED AGREEMENTS IN EUROPEAN HTA: NOT A ROUTINE UNCERTAINTY TOOL, BUT A SELECTIVE ACCESS MECHANISM
Aug 11, 2026, 17:16 PM -
SYMPTOM BURDEN IN BRONCHIECTASIS: RESULTS OF A TARGETED LITERATURE REVIEW AND PATIENT FOCUS GROUPS
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY, SAFETY, AND NETWORK META-ANALYSIS FEASIBILITY OF IMMUNOTHERAPY-BASED COMBINATION THERAPIES FOR ADVANCED RENAL CELL CARCINOMA: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
REPORTING OF ARTIFICIAL INTELLIGENCE (AI) USE IN NICE CLINICAL GUIDELINES AND TECHNOLOGY APPRAISALS: A STRUCTURED REVIEW
Aug 11, 2026, 17:16 PM -
A HYBRID, MULTI-SOURCE REAL-WORLD EVIDENCE FRAMEWORK FOR POST-AUTHORIZATION STUDIES: DESIGN CONSIDERATIONS FOR EU JOINT CLINICAL ASSESSMENT READINESS
Aug 11, 2026, 17:16 PM -
THE VALUE OF INVESTING IN HIV CARE IN THE NETHERLANDS: SOCIETAL GAIN AND REMAINING CHALLENGES
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL, CLINICAL, ECONOMIC, AND HUMANISTIC BURDEN OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE UNITED ARAB EMIRATES: A MARKOV STATE-TRANSITION MODELING STUDY
Aug 11, 2026, 17:16 PM -
MODELING THE POTENTIAL PUBLIC HEALTH IMPACT OF INTRODUCING ONE-DOSE BOOSTER MENINGOCOCCAL B VACCINATION (4CMENB) FOR ADOLESCENTS IN ENGLAND, SPAIN AND ITALY
Aug 11, 2026, 17:16 PM
